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Background
Cardiac hypertrophy represents a primary mechanism by
which heart is remodeled in response to a variety of intrin-
sic and extrinsic stimuli. The underlying role of inflamma-
tion in the molecular mechanisms of cardiac hypertrophy
remains incompletely elucidated. We are investigating the
role of epigenetic mechanisms in the regulation of cardiac
hypertrophy induced by interleukin 18 (IL-18) using in
vivo and in vitro models. Daily intra-peritoneal adminis-
tration of interleukin 18 for one week in Balb/c mice
induced cardiac hypertrophy as judged by increased ratios
of their heart and lung weights to total body weights, and
enhanced thickness of their ventricular walls. The hearts
of IL-18-treated mice also elicited an increased expression
of atrial naturetic factor, desmin and skeletal α-actin genes
and a concomitant switch in the rate of expression of α-
and β-myosin heavy chain genes. Both the gross histolog-
ical manifestations of cardiac hypertrophy and altered
gene expression were greatly normalized by co-adminis-
tration of histone deacetylase (HDAC) inhibitors, m-car-
boxycinnamic acid bis-hydroxamide (CBHA) or
trichostatin A (TSA). Evidently, IL-18 and HDAC inhibi-
tors modulated the signal transduction pathways that
elicit the program of hypertrophy-specific gene expres-
sion. Our data revealed that chromatin remodeling and
expression of PTEN (phosphatase and tensin homolog)
by CBHA and TSA was mechanistically related to amelio-
ration of cardiac hypertrophy. A brisk induction of PTEN
by inhibitors of HDACs led to attenuation of IL-18-
induced PI3K-Akt/protein kinase B signal transduction
pathway.
To extend these observations, we also undertook genome-
wide comparisons of the transcriptomes of murine hearts
treated with IL-18 in the presence and absence of HDAC
inhibitors. We observed that a cohort of genes that regu-
late cell signaling, inflammatory response, proteasome
degradation and apoptosis were differentially regulated in
response to IL-18, TSA and CBHA. We will discuss mech-
anistic implications of these data for epigenetic regulation
of cardiac hypertrophy and its reversal by HDAC inhibi-
tors.
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